Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach

Overview

Journal Polymers (Basel)

Publisher MDPI

Date 2024 Mar 13

PMID 38475368

Authors

Elena O Bakhrushina

Iosif B Mikhel

Valeriya M Kondratieva

Irina M Zubareva

Svetlana I Kosenkova

Anastasiya V Belyatskaya

Olga I Stepanova

Ivan I Krasnyuk Jr

Tatyana V Grebennikova

Ivan I Krasnyuk

Affiliations

Soon will be listed here.

Abstract

The rapid growth in the prevalence of infectious diseases requires timely action from drug developers. In recent years, the COVID-19 pandemic has demonstrated the unpreparedness of the population for such emergencies. The introduction of modern methods of Design of Experiments (DoE) is required to accelerate the process of drug development and bring a drug to market. The main objective of this study was to develop an ion-triggered in situ system for intranasal delivery of VLP using a Quality by Design approach. Based on a literature review and initial studies, the key QTPP, CQA, CPP, and CMA were identified to develop a novel delivery system for virus-like particles. As a result of the studies on the quality attributes of the developed delivery system, an ion-triggered in situ gel meeting all the specified parameters was obtained using the Quality by Design method.

Citing Articles

Development of an Intranasal In Situ System for Ribavirin Delivery: In Vitro and In Vivo Evaluation.

Mikhel I, Bakhrushina E, Petrusevich D, Nedorubov A, Appolonova S, Moskaleva N Pharmaceutics. 2024; 16(9).

PMID: 39339163 PMC: 11435039. DOI: 10.3390/pharmaceutics16091125.

References

Safonova E, Razina T, Zueva E, Lopatina K, Efimova L, Gurev A . [Prospects for the use of plant polysaccharides in complex treatment of malignant tumors]. Eksp Klin Farmakol. 2012; 75(9):42-7. View

Sztupecki W, Rhazi L, Depeint F, Aussenac T . Functional and Nutritional Characteristics of Natural or Modified Wheat Bran Non-Starch Polysaccharides: A Literature Review. Foods. 2023; 12(14). PMC: 10379113. DOI: 10.3390/foods12142693. View

Bakhrushina E, Mikhel I, Kondratieva V, Demina N, Grebennikova T, Krasnyuk Jr I . Main Aspects of Pharmaceutical Development of Immunobiological Drugs for Intranasal Administration. Curr Pharm Biotechnol. 2023; 25(11):1394-1405. DOI: 10.2174/0113892010260017231002075152. View

Zhang Y, Li Q, Hu J, Wang C, Wan D, Li Q . Nasal Delivery of Cinnarizine Thermo- and Ion-Sensitive In Situ Hydrogels for Treatment of Microwave-Induced Brain Injury. Gels. 2022; 8(2). PMC: 8872061. DOI: 10.3390/gels8020108. View

Nagai M, Moriyama M, Ichinohe T . Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection. mBio. 2021; 12(4):e0159821. PMC: 8406166. DOI: 10.1128/mBio.01598-21. View

Sanap S, Bisen A, Kedar A, Yadav K, Krishna A, Akhir A . Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis. Int J Biol Macromol. 2022; 222(Pt B):2785-2795. DOI: 10.1016/j.ijbiomac.2022.10.058. View

Kis Z, Kontoravdi C, Dey A, Shattock R, Shah N . Rapid development and deployment of high-volume vaccines for pandemic response. J Adv Manuf Process. 2021; 2(3):e10060. PMC: 7361221. DOI: 10.1002/amp2.10060. View

Shah V, Sharma M, Pandya R, Parikh R, Bharatiya B, Shukla A . Quality by Design approach for an in situ gelling microemulsion of Lorazepam via intranasal route. Mater Sci Eng C Mater Biol Appl. 2017; 75:1231-1241. DOI: 10.1016/j.msec.2017.03.002. View

Cho C, Hwang S, Gu M, Kim C, Kim S, Ju D . Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems. Tissue Eng Regen Med. 2021; 18(5):693-712. PMC: 8310561. DOI: 10.1007/s13770-021-00373-w. View

10.

Li C, Li C, Liu Z, Li Q, Yan X, Liu Y . Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan. Int J Pharm. 2014; 474(1-2):123-33. DOI: 10.1016/j.ijpharm.2014.08.023. View

11.

Yong C, Oh Y, Kim Y, Kim J, Yoo B, Rhee J . Physicochemical characterization and in vivo evaluation of poloxamer-based solid suppository containing diclofenac sodium in rats. Int J Pharm. 2005; 301(1-2):54-61. DOI: 10.1016/j.ijpharm.2005.05.037. View

12.

Fahmy U, Badr-Eldin S, Ahmed O, Aldawsari H, Tima S, Asfour H . Intranasal Niosomal Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and / Evaluation. Pharmaceutics. 2020; 12(6). PMC: 7356232. DOI: 10.3390/pharmaceutics12060485. View

13.

Marcotuli I, Colasuonno P, Hsieh Y, Fincher G, Gadaleta A . Non-Starch Polysaccharides in Durum Wheat: A Review. Int J Mol Sci. 2020; 21(8). PMC: 7215680. DOI: 10.3390/ijms21082933. View

14.

Hocharoen L, Noppiboon S, Kitsubun P . Toward QbD Process Understanding on DNA Vaccine Purification Using Design of Experiment. Front Bioeng Biotechnol. 2021; 9:657201. PMC: 8153680. DOI: 10.3389/fbioe.2021.657201. View

15.

Islam M, Park T, Reesor E, Cherukula K, Hasan A, Firdous J . Mucoadhesive Chitosan Derivatives as Novel Drug Carriers. Curr Pharm Des. 2015; 21(29):4285-309. DOI: 10.2174/1381612821666150901103819. View

16.

Carranza T, Zalba-Balda M, Baraibar M, de la Caba K, Guerrero P . Effect of sterilization processes on alginate/gelatin inks for three-dimensional printing. Int J Bioprint. 2023; 9(1):645. PMC: 9947484. DOI: 10.18063/ijb.v9i1.645. View

17.

Chen Y, Liu Y, Xie J, Zheng Q, Yue P, Chen L . Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine. Int J Nanomedicine. 2020; 15:10435-10451. PMC: 7767747. DOI: 10.2147/IJN.S265659. View

18.

Taymouri S, Shahnamnia S, Mesripour A, Varshosaz J . and evaluation of an ionic sensitive gel containing nanotransfersomes for aripiprazole nasal delivery. Pharm Dev Technol. 2021; 26(8):867-879. DOI: 10.1080/10837450.2021.1948571. View

19.

Teaima M, Helal D, Alsofany J, El-Nabarawi M, Yasser M . Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics. 2022; 14(11). PMC: 9694345. DOI: 10.3390/pharmaceutics14112405. View

20.

van de Berg D, Kis Z, Behmer C, Samnuan K, Blakney A, Kontoravdi C . Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases. NPJ Vaccines. 2021; 6(1):65. PMC: 8085199. DOI: 10.1038/s41541-021-00322-7. View